G1 Therapeutics (GTHX) Stock Price, News & Analysis
Company Description
G1 Therapeutics (NASDAQ: GTHX) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $377.2M, ranking #3,938 among all listed U.S. companies by market cap.
GTHX stock has gained 379.9% over the past year. Shares last traded at $7.15.
This page provides a comprehensive overview of GTHX stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
G1 Therapeutics (GTHX) stock last traded at $7.15. Over the past 12 months, the stock has gained 379.9%. At a market capitalization of $377.2M, GTHX is classified as a small-cap stock with approximately 52.8M shares outstanding.
GTHX Rankings
Latest News
G1 Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, acquisition, clinical trial. View all GTHX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GTHX Company Profile & Sector Positioning
G1 Therapeutics (GTHX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.